Highly awaited Alzheimer's drug hit by delays
Credit: Unsplash/CC0 Public DomainEli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for pa
Updated on: March 19,2024
10
Highly awaited Alzheimer's drug hit by delays
Credit: Unsplash/CC0 Public DomainEli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for pa
Updated on:March 19,2024
10